Accredo is a specialty pharmacy dedicated to comprehensive patient support programs
You’ve invested time and resources into creating therapies designed to improve the health of individuals living with chronic and complex conditions. In fact, recent estimates have valued investment in new drug development at $314M to $2.8B.1
Yet, the barriers to launching drugs are high. Without a specialty pharmacy partner with experience managing complex therapies, your patients face delayed treatment. As a leader in patient support for limited, exclusive, rare, and gene therapies, Accredo ensures that patients have the resources and assistance they need to benefit from your therapies.
- 1
Policy & Medicine, March 2019. “A Tough Road: Cost to Develop One New Drug is $2.6 Billion; Approval Rare for Drugs Entering Clinical Development is Less Than 12%.” https://www.policymed.com/2014/12/a-tough-road-cost-to-develop-one-new-drug-is-26-billion-approval-rate-for-drugs-entering-clinical-de.html